Dana Zhang joined Ambrx as Vice President of Finance. In this role, she is responsible for overseeing Ambrx finance and accounting operations. Dana has over 20 years of pharmaceutical industry and international business experience with an emphasis on finance, operations, process improvement and business development. She has extensive experience with marketing partnerships, acquisitions and debt and equity financings. Prior to joining Ambrx, Dana was Head of Finance for Kalypsys, AnaptysBio and Cylene Pharmaceuticals. She gained significant experience with business practices in China through her global controller role at BioDuro. Dana is a Certified Public Accountant. She earned her B.S. in Biology from Harbin Normal University in China, and an MBA in Finance from the University of Phoenix.